0000899243-23-000500.txt : 20230104 0000899243-23-000500.hdr.sgml : 20230104 20230104112043 ACCESSION NUMBER: 0000899243-23-000500 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230104 DATE AS OF CHANGE: 20230104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hirsch Susan B CENTRAL INDEX KEY: 0001827663 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 23504888 MAIL ADDRESS: STREET 1: 280 OLD SOMERSET ROAD CITY: WATCHUNG STATE: NJ ZIP: 07069 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-03 0 0001098972 AGENUS INC AGEN 0001827663 Hirsch Susan B C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421 1 0 0 0 Common Stock 2023-01-03 4 A 0 7239 2.59 A 108725 D Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock. $2.590 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued. /s/ Christine Klaskin as Attorney-in-Fact for Susan B. Hirsch 2023-01-04